Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.

Buter, J

Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1993 - 2108-13 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

0959-8049

10.1016/0959-8049(93)90044-g doi


Adult
Aged
Carcinoma, Renal Cell--drug therapy
Female
Humans
Infusions, Intravenous
Injections, Subcutaneous
Interleukin-2--administration & dosage
Kidney Neoplasms--pathology
Male
Melanoma--drug therapy
Middle Aged
Muromonab-CD3--administration & dosage